ClassID:

94456

C07D235/32 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2; Nitrogen atoms not forming part of a nitro radical Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof

Recent Application in this class:
#1
20250214945
2025-07-03

THIOBENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF

#2
20240116897
2024-04-11

BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

#3
20230391753
2023-12-07

THIOBENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF

#4
20220055993
2022-02-24

Compounds for treating proliferative diseases

#5
20210228747
2021-07-29

Compositions and methods for the treatment and imaging of cancer

#6
20210205271
2021-07-08

Mebendazole prodrugs with enhanced solubility and oral bioavailability

#7
20200385369
2020-12-10

NEW BENZIMIDAZOLES DERIVATIVES AS TEC KINASES FAMILY INHIBITORS

#8
20200377505
2020-12-03

BENZIMIDAZOLES AND AZA-BENZIMIDAZOLES, AND METHODS OF USE THEREOF

#9
20200223803
2020-07-16

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

#10
20200199078
2020-06-25

Compounds for treating proliferative diseases

#11
20190016686
2019-01-17

SALTS OF COMPOUNDS HAVING A BENZIMIDAZOLIC STRUCTURE, USES AND PROCESS FOR THE PREPARATION THEREOF

#12
20180319781
2018-11-08

Benzimidazoles derivatives as Tec kinases family inhibitors

#13
20180022709
2018-01-25

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

#14
20160046625
2016-02-18

BENZIMIDAZOLE AND AZABENZIMIDAZOLE COMPOUNDS THAT INHIBIT ANAPLASTIC LYMPHOMA KINASE

#15
20150228985
2015-08-13

Carbendazim-based catalytic materials

#16
20150158833
2015-06-11

Sulfonamide derivative having PGD2 receptor antagonistic activity

#17
20150065495
2015-03-05

Substituted-1-benzo[]imidazole series compounds as lysine-specific demethylase 1 (LSD1) inhibitors

#18
20140228378
2014-08-14

N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists

#19
20140088167
2014-03-27

Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides

#20
20140045909
2014-02-13

DENIBULIN DI-HYDROCHLORIDE

#21
20130303782
2013-11-14

PROCESS FOR PREPARATION OF ALBENDAZOLE

#22
20130041002
2013-02-14

Denibulin di-hydrochloride

#23
20130018040
2013-01-17

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

#24
20110288139
2011-11-24

Substituted amino-benzimidazoles, medicaments comprimising said compound, their use and their method of manufacture

#25
20100273793
2010-10-28

6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as C-MET inhibitors

#26
20100136524
2010-06-03

Target protein and target gene in drug designing and screening method

#27
20100069638
2010-03-18

Sulfonamide derivative having PGD2 receptor antagonistic activity

#28
20100063040
2010-03-11

Sulfonamide derivative having PGD2 receptor antagonistic activity

#29
20090306077
2009-12-10

N- (2-aminophenyl) benzamide derivative having urea structure

#30
20090203743
2009-08-13

Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors

#31
20090023669
2009-01-22

Antibacterial agents

#32
20080176842
2008-07-24

BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORS

#33
20070249600
2007-10-25

CHEMICAL COMPOUNDS

#34
20070191444
2007-08-16

Benzimidazolyl derivatives

#35
20060264492
2006-11-23

Benzimidazole vascular damaging agents

#36
20060264483
2006-11-23

Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

#37
20060241301
2006-10-26

Urea derivatives and their use as tyrosinkinase inhibitors

#38
20060199822
2006-09-07

Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

#39
20060172936
2006-08-03

Sulfonamide inhibitors of aspartyl protease

#40
20050288348
2005-12-29

Compounds and methods for use thereof in the treatment of cancer

#41
20050171175
2005-08-04

Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

#42
20050014811
2005-01-20

Substituted benzimidazole compounds and their use for the treatment of cancer